Abiopharma

🔍 Ahmed Elizabeth Claire (Executive)

Company: Unum Group (UNM)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Sold 12,000 shares of Common Stock at $80.14 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 42,587.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Includes 14,900 restricted stock units and 27,687 shares of common stock. All restricted stock units ("stock-settled RSUs") may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.
• F2: Beneficial ownership amount accounts for the exempt acquisition of 22.821 shares of common stock under the issuer's employee stock purchase plan since the date of the reporting person's prior Form 4.